hit counter
Alpine Immune Sciences, Inc. (ALPN) Stock News Sentiment & Price - Sentifly
ALPN - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Alpine Immune Sciences, Inc. (ALPN)

USA
Biotechnology
NASDAQ
ALPN Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
ALPN Latest news
Zacks Investment Research
Positive
3 Small Biotech Stocks in Focus on World Arthritis Day
2021-10-12 10:58

Here we discuss three drugs or biotech companies with promising candidates in their pipeline for Arthritis indications.

Zacks Investment Research
Positive
Alpine Immune Sciences, Inc. (ALPN) Surges 6.2%: Is This an Indication of Further Gains?
2021-09-28 10:50

Alpine Immune Sciences, Inc. (ALPN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Business Wire
Neutral
Alpine Immune Sciences Announces $91 Million Private Placement
2021-09-15 08:05

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced it has entered into a definitive securities purchase agreement for the sale of common stock and prefunded warrants, as described below, in a private placement with certain institutional and other accredited investors for gross proceeds to Alpine of approximately $91 millio

Business Wire
Neutral
Alpine Immune Sciences Announces Participation in September Investor Conferences
2021-09-07 16:05

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences Announces Participation in September Investor Conferences

Seeking Alpha
Neutral
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q2 2021 Results - Earnings Call Transcript
2021-08-10 22:35

Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
Alpine Immune Sciences, Inc. (ALPN) Reports Q2 Loss, Tops Revenue Estimates
2021-08-10 19:19

Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -58.62% and 9.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Benzinga
Positive
Alpine Immune Sciences: Q2 Earnings Insights
2021-08-10 16:53

Shares of Alpine Immune Sciences (NASDAQ:ALPN) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 13.21% year over year to ($0.46), which missed the estimate of ($0.40).

Business Wire
Neutral
Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial Results
2021-08-10 16:05

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial Results

Business Wire
Neutral
Alpine Immune Sciences to Report Second Quarter 2021 Financial Results and to Present at Upcoming Investor Conferences
2021-08-04 08:00

SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences to Report Second Quarter 2021 Financial Results and to Present at Upcoming Investor Conferences

Zacks Investment Research
Positive
Will Alpine Immune Sciences, Inc. (ALPN) Report Negative Q2 Earnings? What You Should Know
2021-08-03 16:47

Alpine Immune Sciences, Inc. (ALPN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Loading more news...